References
- Gejyo F, Yamada T, Odani S, Nakagawa Y, Arakawa M, Kunitomo T, et al. A new form of amyloid protein associated with chronic hemodialysis was identified as beta 2-microgrobulin. Biochem Biophys Res Commun 1985;129:701–6.
- Gorevic PD, Munoz PC, Casey TT, DiRaimond CR, Stone WJ, Prelli FC, et al. Polymerization of intact beta 2-microgrobulin in tissue causes amyloidosis in patients on chronic hemodialysis. Proc Natl Acad Sci USA 1986;83:7908–12.
- Hammer RE, Maika SD, Richardson JA, Tang JP, Taurog JD. Spontaneous inflammatory disease in transgenic rats expressing HLAB-27 and Human beta 2-m: an animal model of HLAB-27-associated human disorders. Cell 1990;63: 1099–112.
- Rath HC, Herfarth HH, Ikeda JS, Grenther WB, Hamm TE, Balish JE, et al. Normal lumina' bacteria, especially bacteroides species mediate chronic colitis, gasteritis, and arthritis in HLA-B27/Human beta 2 microglobulin transgenic rats. J Clin Invest 1996;98:945–53.
- Taurog JD, Richardson JA, Croft JT, Simmons A, Zhou M, Fernandez-Sueiro JL, et al. The germfree state prevents develop-ment of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med 1994;180: 2359–64.
- Aiko S, Fuseler J, Grisham MB. Effect of nitric oxide synthase inhibition or sulfasalazine on the spontaneous colitis observed in HLA-B27 transgenic rats. J Pharm Exp Ther 1998;284: 722–7.
- Trentham DE, Townes AS, Kang AH. Autoimmunity to type II collagen: an experimental model of arthritis. J Exp 1977;146: 857–68.
- Sasai M, Saeki Y, Ohshima S, Nishioka K, Mima T, Tanaka T, et al. Delayed onset and reduced severity of collagen-induced arthritis in interleukin-6-defficient mice. Arthritis Rheum 1999;42: 1635–43.
- Wright J, Calkins E, Humphrey R. Potassium permanganate reac-tion in amyloidosis: a histologic method to assist in differentiating forms of this disease. Lab Invest 1977;36: 274.
- Campistol JM, Sole M, Munoz-Gomez J, Ftiba J, Ramon R, Revert L. Pathological fractures in patients who have amyloidosis associ-ated with dialysis. J Bone Joint Surg Am 1990;72:568–73.
- Ayers DC, Athanasou NA, Woods CG, Duthie RB. Dialysis arthropathy of the hip. Clin Orthop 1993;290:216–24.
- Kuntz D, Naveeau B, Bardin T, Drueke T, Treves R, Dry11 A. Destructive spondylarthropaty in hemodialyzed patients, a new syndrome. Arthitis Rheum 1984;27:369–75.
- Sakalkale DP, Hozack WJ, Rothman RH. Total hip arthroplasty in patients on long-term renal dialysis. J arthroplasty 1999;14: 571–5.
- Tateishi H, Maeda M, Yoh K, Nakano T, Nakano K. Pathological fracture associated with amyloid deposition in bone of chronic hemodialysis patient. Chin Orthop Relat Res 1992;2074:300–4.
- Naito N, Ogata K, Shiota E, Nakamoto M, Goya T. Hip arthro-plasty in haemodialysis patients. J Bone Joint Surg Br 1994;76: 428–31.
- DiRaimondo CR, Casey TT, DiRaimondo CV, Stone WJ. Patho-logical fracture associated with idiopathic amyloidosis of bone in chronic hemodialysis patients. Nephron 1986;43:22–7.
- Brancaccio D, Gallieni M, Niwa T, Braidotti P, Coggi G. Ultra-structural localization of advanced glycation end products and beta 2-microglobulin in dialysis amyloidosis. J Nephrol 2000;13: 129–36.
- Nokura K, Koga H, Yamamoto H, Kimura A, Tamai H, Yazaki S, et al. Dialysis-related spinal canal stenosis: a clinicopathological study on amyloid deposition and its AGE modification J Neuro Sci 2000;178:114–23.
- Miyata T, Oda 0, Inagi Y. Beta 2-microglobulin modified with advanced glycation end products is a major component of hemo-dialysis-associated amyloidosis. J Clini Invest 1993;92: 1243–52.
- Miyata T, Iida Y, Sato M, Yamada N. Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis associated amyloidosis. J Clin Invest 1994;93:521–8.
- Iida Y, Miyata T, Inagi R. Beta 2-microglobulin modified with advanced glycation end products induces interleukin 6 from hman macrophage: role in pathogenesis of hemodialysis-associated amy-loidosis. Biochem Biophys Res Commum 1994;201: 1235–41.
- Hou FF, Chertow GM, Kay J, Boyce J, Lazarus M, Braatz JA, Owen Jr WF. Interaction between beta 2-microglobulin and advanced glycation end products in the development of dialysis related-amyloidosis. Kidney Int 1997;51:1514–9.
- Miyata T, Notoya K, Yoshida K, Hone K, Maeda K, Kurokawa K, et al. Advanced glycation end products enhance osteoclast-induced bone resorption in cultured mouse unfractionated devitalized bone particles. J Am Soc Nephrol 1997;8:260–70.